Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Diffuse Large B-cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07231250
What this trial is testing

Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaChemo-free TherapyBispecific Antibody
Li Zhiming 40
Large-scale testing (Phase 3)UnknownNCT05097443
What this trial is testing

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Who this might be right for
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsHigh Grade B-Cell Lymphoma, Not Otherwise SpecifiedDiffuse Large B-cell Lymphoma+2 more
Shandong Provincial Hospital 130
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT03837873
What this trial is testing

DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 118
Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Large-scale testing (Phase 3)UnknownNCT04789434
What this trial is testing

PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT

Who this might be right for
Lymphoma, Large B-Cell, DiffuseTransplantationChemotherapy
Ruijin Hospital 94
Large-scale testing (Phase 3)Not Yet RecruitingNCT07647432
What this trial is testing

HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV

Who this might be right for
Plasmablastic LymphomaHivConsolidation
University of Illinois at Chicago 17
Testing effectiveness (Phase 2)Study completedNCT01234467
What this trial is testing

Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaLymphoma, Diffuse Large-CellDiffuse Large-Cell Lymphoma+1 more
UNC Lineberger Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00971763
What this trial is testing

Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
University College, London 62
Testing effectiveness (Phase 2)Study completedNCT01040871
What this trial is testing

Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Millennium Pharmaceuticals, Inc. 164
Testing effectiveness (Phase 2)Study completedNCT00670358
What this trial is testing

Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma

Who this might be right for
Lymphoma
Mayo Clinic 138
Very early researchLooking for participantsNCT04139304
What this trial is testing

Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Who this might be right for
Plasmablastic LymphomaAnn Arbor Stage I Diffuse Large B-Cell LymphomaAnn Arbor Stage II Diffuse Large B-Cell Lymphoma+2 more
AIDS Malignancy Consortium 15
Testing effectiveness (Phase 2)Looking for participantsNCT07680933
What this trial is testing

Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
The Affiliated Hospital of Xuzhou Medical University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07538180
What this trial is testing

Serplulimab, Chidamide, and Rituximab Followed by Sequential R-CHOP for Newly Diagnosed Elderly MYC/BCL2 Double-Expressor DLBCL

Who this might be right for
Newly Diagnosed MYC/BCL2 Double-expressor DLBCL
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT00690560
What this trial is testing

Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma

Who this might be right for
Lymphoma
Centre Antoine Lacassagne 30
Not applicableEnded earlyNCT01144754
What this trial is testing

Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT

Who this might be right for
LymphomaNon-Hodgkin's Lymphoma
Stanford University 1
Testing effectiveness (Phase 2)UnknownNCT05498259
What this trial is testing

Orelabrutinib With R-CHOP-like Regimen for Patients With Newly Diagnosed Untreated Non-GCB DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital of Soochow University 46
Testing effectiveness (Phase 2)Study completedNCT04164368
What this trial is testing

Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients

Who this might be right for
Double Expressor Lymphoma
Fudan University 67
Early research (Phase 1)Study completedNCT03283202
What this trial is testing

Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors

Who this might be right for
Diffuse B-Cell Lymphoma
Celgene 35
Testing effectiveness (Phase 2)UnknownNCT05200312
What this trial is testing

A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma

Who this might be right for
Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 36
Next Page